Tabula Rasa HealthCare, Inc. (TRHC) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Tabula Rasa HealthCare, Inc. (TRHC) trades at $10.50 with AI Score 39/100 (Grade D). Tabula Rasa HealthCare, Inc. is a healthcare technology company focused on medication safety and optimization. Market cap: $284M, Sector: Healthcare.
Price as of Jul 23, 2026 · Last analyzed: May 10, 2026Analyst Coverage for TRHC: TRHC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TRHC against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
TRHC: 1/3 scored disciplines lean bearish. Dominant signal: Ken Griffin bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Tabula Rasa HealthCare, Inc. (TRHC) Healthcare & Pipeline Overview
Tabula Rasa HealthCare, Inc. (TRHC) delivers medication risk management solutions through its cloud-based software and services. The company's platforms, like EireneRx and MedWise, support healthcare providers in optimizing medication regimens and improving patient outcomes, serving healthcare organizations, pharmacies, and health plans across the United States.
What Is the Investment Thesis for TRHC?
Tabula Rasa HealthCare presents an investment opportunity within the growing healthcare technology sector, specifically in medication risk management. The company's cloud-based platforms, such as EireneRx and MedWise, address the critical need for medication optimization and safety, potentially reducing adverse drug events and improving patient outcomes. The increasing adoption of value-based care models and the focus on reducing healthcare costs could drive demand for Tabula Rasa's solutions. However, the company's negative profit margin of -25.8% indicates profitability challenges. Successful execution of growth strategies and a shift towards profitability are crucial for long-term value creation. Investors should closely monitor the company's ability to expand its customer base, improve operational efficiency, and achieve sustainable profitability.
Based on FMP financials and quantitative analysis
TRHC Key Highlights
- Market capitalization of $284M reflects investor valuation of the company's future growth potential.
- Negative profit margin of -25.8% indicates ongoing challenges in achieving profitability.
- Gross margin of 22.3% suggests potential for improvement through operational efficiencies and pricing strategies.
- The company serves approximately 150 healthcare organizations, indicating a significant market presence.
- Partnerships with 350 health plans and approximately 18,000 retail pharmacies demonstrate a broad distribution network.
Who Are TRHC's Competitors?
TRHC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| DGX Quest Diagnostics Incorporated | $227.90 | +8.61% | $25.2B | 75 |
| CVS CVS Health Corporation | $106.89 | -1.10% | $136B | 76 |
| UNH UnitedHealth Group Incorporated | $431.31 | -1.16% | $392B | 80 |
| VHIBF Vitalhub Corp. | $4.63 | -2.53% | $293M | 63 |
| DLHTF Dialogue Health Technologies Inc. | $3.79 | +0.59% | $255M | 56 |
| SMFR Sema4 Holdings Corp. | $0.31 | +26.78% | $246M | 60 |
| SPOK Spok Holdings, Inc. | $10.46 | -1.74% | $219M | 83 |
| SLP Simulations Plus, Inc. | $18.33 | +0.44% | $371M | 81 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TRHC's Key Strengths?
- Comprehensive suite of medication risk management solutions.
- Cloud-based technology platform.
- Established relationships with healthcare organizations and pharmacies.
- Expertise in medication safety and optimization.
What Are TRHC's Weaknesses?
- Negative profit margin.
- High operating expenses.
- Reliance on a limited number of key customers.
- Competition from larger healthcare technology companies.
What Could Drive TRHC Stock Higher?
- Potential acquisitions or partnerships to expand product offerings and market reach.
- Increasing adoption of value-based care models driving demand for medication risk management solutions.
- Expansion of the company's presence within the PACE market.
- Development and launch of new AI-powered tools for medication optimization.
What Are the Key Risks for TRHC?
- Financial-distress signal — its Altman Z-Score of -0.69 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Regulatory changes affecting medication management practices.
- Increased competition from larger healthcare technology companies.
- Cybersecurity risks and data breaches.
- Economic downturn affecting healthcare spending.
- Challenges in achieving and maintaining profitability.
What Are the Growth Opportunities for TRHC?
- Expansion within the PACE market: Tabula Rasa's CareVention HealthCare segment offers solutions tailored for Programs of All-Inclusive Care for the Elderly (PACE). With the aging population and increasing demand for comprehensive care programs, expanding its presence within the PACE market represents a significant growth opportunity. The PACE market is projected to continue growing, driven by the need to provide integrated care for older adults with complex health needs. Timeline: Ongoing.
- Increased adoption of medication therapy management (MTM) services: Tabula Rasa's MedWise HealthCare segment provides medication therapy management (MTM) software and services. As healthcare providers and payers increasingly recognize the value of MTM in improving patient outcomes and reducing healthcare costs, the demand for MTM solutions is expected to grow. This trend presents an opportunity for Tabula Rasa to expand its MTM business and attract new customers. Timeline: Ongoing.
- Strategic partnerships and acquisitions: Tabula Rasa can pursue strategic partnerships and acquisitions to expand its product offerings, enter new markets, and enhance its competitive position. Collaborating with other healthcare technology companies or acquiring complementary businesses can accelerate growth and create synergies. Identifying and integrating synergistic acquisitions will be key to capitalizing on this opportunity. Timeline: Ongoing.
- Leveraging data analytics and artificial intelligence: Tabula Rasa can leverage data analytics and artificial intelligence (AI) to enhance its medication risk management solutions and provide more personalized and proactive care. By analyzing patient data and identifying patterns, the company can develop AI-powered tools that predict and prevent adverse drug events, optimize medication regimens, and improve patient outcomes. Timeline: Ongoing.
- Expanding into new geographic markets: While Tabula Rasa primarily operates in the United States, expanding into new geographic markets represents a long-term growth opportunity. The need for medication risk management solutions exists globally, and Tabula Rasa can leverage its expertise and technology to serve healthcare organizations and patients in other countries. Conducting market research and adapting its solutions to meet local needs will be crucial for successful international expansion. Timeline: Future.
What Opportunities Does TRHC Have?
- Expansion within the PACE market.
- Increased adoption of medication therapy management (MTM) services.
- Strategic partnerships and acquisitions.
- Leveraging data analytics and artificial intelligence.
What Threats Does TRHC Face?
- Regulatory changes affecting medication management.
- Competition from new entrants in the healthcare technology market.
- Cybersecurity risks and data breaches.
- Economic downturn affecting healthcare spending.
What Are TRHC's Competitive Advantages?
- Proprietary technology: Cloud-based platforms and algorithms for medication risk management.
- Data assets: Accumulation of patient medication data and clinical insights.
- Established relationships: Partnerships with healthcare organizations, pharmacies, and health plans.
- Expertise: Deep understanding of medication safety and optimization.
What Does TRHC Do?
Founded in 2009 and headquartered in Moorestown, New Jersey, Tabula Rasa HealthCare, Inc. operates as a healthcare technology company dedicated to improving medication safety and efficacy. The company provides a suite of cloud-based software solutions and services designed to help healthcare organizations, pharmacies, and health plans optimize medication regimens, reduce adverse drug events, and improve patient outcomes. Tabula Rasa operates through two segments: CareVention HealthCare and MedWise HealthCare. CareVention HealthCare focuses on providing solutions for Programs of All-Inclusive Care for the Elderly (PACE), offering tools like TruChart, an electronic health record (EHR) system, and PACElogic, a platform for care coordination and financial management. MedWise HealthCare offers platforms like EireneRx, a medication decision-support and e-prescribing platform, and MedWise medication therapy management software. These platforms aid in identifying and resolving medication-related problems. Additionally, Tabula Rasa offers DoseMeRx, a decision support software for dose optimization, and PrescribeWellness, a patient engagement center platform. The company also provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services. As of December 31, 2021, Tabula Rasa served approximately 150 healthcare organizations, 350 health plans, and approximately 18,000 retail pharmacies.
What Products and Services Does TRHC Offer?
- Provides cloud-based medication decision-support and e-prescribing platforms.
- Offers medication therapy management software to identify and resolve medication-related problems.
- Delivers electronic health records (EHR), care coordination, and financial management solutions for PACE programs.
- Provides dose optimization software leveraging pharmacokinetic drug models and patient characteristics.
- Offers a patient engagement center platform.
- Provides clinical pharmacist collaboration and prescription fulfillment services.
- Offers pharmacy benefit management services.
- Provides health plan management services, including risk adjustment.
How Does TRHC Make Money?
- Software-as-a-Service (SaaS) model: Generates revenue through subscriptions to its cloud-based software platforms.
- Service fees: Charges fees for clinical pharmacist collaboration, prescription fulfillment, and pharmacy benefit management services.
- Health plan management services: Earns revenue from providing risk adjustment and third-party administrator services to health plans.
What Industry Does TRHC Operate In?
Tabula Rasa HealthCare operates in the healthcare information technology sector, which is experiencing significant growth driven by the increasing adoption of digital health solutions and the need for improved healthcare efficiency. The market is competitive, with companies offering various solutions for medication management, electronic health records, and care coordination. Tabula Rasa differentiates itself through its focus on medication risk management and its suite of integrated cloud-based platforms. The company's solutions cater to healthcare organizations, pharmacies, and health plans, positioning it within a broad segment of the healthcare ecosystem.
Who Are TRHC's Key Customers?
- Healthcare organizations: Hospitals, clinics, and integrated delivery networks.
- Pharmacies: Retail pharmacies and specialty pharmacies.
- Health plans: Managed care organizations and government-sponsored health plans.
- Programs of All-Inclusive Care for the Elderly (PACE): Organizations providing comprehensive care to older adults.
F-Score 3/9Financial Health
Tabula Rasa HealthCare, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.69 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on assets is -20.1%, showing how much profit it generates from its asset base. Its free cash flow yield is -7.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.67 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -30.3%, the inverse of the P/E and a quick read on earnings relative to price.
TRHC Valuation & Market Position
With a $284M market cap, Tabula Rasa HealthCare, Inc. sits in the micro-cap segment of the market. Relative to its peer group, TRHC's quantitative score of 39/100 is below the peer average of 70/100.
TRHC Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating that those closest to the business believe in its potential.
- Community sentiment has shifted positively, with discussions highlighting new partnerships and innovations in their healthcare technology.
- Analysts have noted an increasing demand for personalized medication management, aligning with TRHC's core services and positioning them well in a growing market.
- Recent product launches have garnered attention, showcasing TRHC's commitment to improving patient outcomes, which resonates well with investors.
Bear Case
- Concerns about regulatory challenges in the healthcare sector have surfaced, potentially impacting TRHC's operational flexibility.
- Some community members express skepticism over the company's ability to scale effectively, given the competitive landscape in healthcare technology.
- Recent earnings reports raised questions about revenue growth sustainability, leading to a cautious outlook among certain analysts.
- Market perception remains mixed, with some investors wary of the company's long-term viability amid ongoing industry changes and economic uncertainties.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
TRHC Latest News
No recent news available for TRHC.
TRHC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TRHC.
Price Targets
Wall Street price target analysis for TRHC.
TRHC MoonshotScore
What does this score mean?
The MoonshotScore rates TRHC 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Brian W. Adams
CEO
Brian W. Adams serves as the Chief Executive Officer of Tabula Rasa HealthCare, Inc. His background includes extensive experience in the healthcare technology and pharmaceutical industries. Prior to joining Tabula Rasa, Adams held leadership positions at various healthcare companies, focusing on strategic planning, business development, and operational management. His expertise spans areas such as medication management, healthcare analytics, and patient engagement. Adams' experience positions him to lead Tabula Rasa in its mission to improve medication safety and optimize patient outcomes.
Track Record: Since assuming the role of CEO, Brian W. Adams has focused on driving growth and improving operational efficiency at Tabula Rasa HealthCare. Key initiatives under his leadership include expanding the company's product offerings, strengthening its partnerships with healthcare organizations, and implementing cost-saving measures. Adams has also emphasized the importance of innovation and leveraging technology to enhance the company's medication risk management solutions.
Tabula Rasa HealthCare, Inc. Healthcare Stock: Key Questions Answered
What does the AI Score mean for TRHC?
TRHC holds an AI Score of 39/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. Tabula Rasa HealthCare, Inc. is a healthcare technology company focused on medication safety and optimization. They provide cloud-based software and services to healthcare organizations …
What does Tabula Rasa HealthCare, Inc. do?
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company focused on medication risk management. The company provides cloud-based software and services to healthcare organizations, pharmacies, and health plans. Its platforms, such as EireneRx and MedWise, help healthcare providers optimize medication regimens, reduce adverse drug events, and improve patient outcomes. Tabula Rasa's solutions address the critical need for medication safety and efficacy in the healthcare industry.
What do analysts say about TRHC stock?
Analyst coverage of Tabula Rasa HealthCare, Inc. typically focuses on the company's growth potential within the healthcare technology sector and its ability to capitalize on the increasing demand for medication risk management solutions. Valuation metrics and growth considerations are key factors in analyst assessments. However, the company's profitability challenges and competitive landscape are also closely monitored. Analyst ratings and price targets reflect varying perspectives on the company's future performance.
What are the main risks for TRHC?
The main risks for Tabula Rasa HealthCare, Inc. include regulatory changes affecting medication management practices, increased competition from larger healthcare technology companies, cybersecurity risks and data breaches, and economic downturns affecting healthcare spending. Additionally, the company faces challenges in achieving and maintaining profitability. These risks could impact Tabula Rasa's financial performance and growth prospects.
How does Tabula Rasa HealthCare, Inc. ensure data privacy and security?
Given the sensitive nature of patient data handled by Tabula Rasa HealthCare, Inc., the company likely implements robust data privacy and security measures. These measures may include encryption, access controls, and compliance with relevant regulations such as HIPAA.
What is Tabula Rasa HealthCare, Inc.'s strategy for expanding its market share?
Tabula Rasa HealthCare, Inc.'s strategy for expanding its market share likely involves a combination of organic growth and strategic acquisitions. The company may focus on expanding its presence within the PACE market, increasing adoption of its medication therapy management (MTM) services, and developing new AI-powered tools for medication optimization.
What are the key factors to evaluate for TRHC?
Tabula Rasa HealthCare, Inc. (TRHC) holds an AI score of 39/100 (low). Not financial advice.
How frequently does TRHC data refresh on this page?
TRHC's price was last updated on Jul 23, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven TRHC's recent stock price performance?
Tabula Rasa HealthCare, Inc. (TRHC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive suite of medication risk management solutions. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data as of 2026-05-10.
- Financial data is based on the most recent available reports.
- Future performance is subject to various risks and uncertainties.